Genetic risk for covid-19 outcomes in COPD
Rui Marçalo(University of Aveiro), Gabriela Moura(University of Aveiro), Lília Andrade(Centro Hospitalar do Baixo Vouga), Carla Valente(Centro Hospitalar do Baixo Vouga), Ana Paula Rodrigues(Microsoft (Brazil)), Nuno Sousa(University of Minho), Alda Marques(University of Aveiro), Sonya Neto(University of Aveiro), Paula Simão(Administração Regional de Saúde de Lisboa e Vale do Tejo), Miguel Pinheiro(University of Aveiro), Manuel A. S. Santos(University of Aveiro)
Cited by 0
Related Papers
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century
|PLoS ONE|2019|185
European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?
|Clinical Microbiology and Infection|2019|140
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries
|Influenza and Other Respiratory Viruses|2021|128
Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017
|Eurosurveillance|2017|125